49Indexed trials
Market Rank #48 · Evidence Tier A
Slovakia
Neuroscience Intelligence
Slovakia neuroscience intelligence: 49 indexed trials, 2 institutions, research score 22.31.
5Recruiting
2Research institutions
22.3Research score
Evidence profile
36Sponsors
15Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 22 · ML priority 22 · Confidence 85 · Evidence 22.3
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
epilepsy9trials
parkinsons6trials
alzheimers6trials
depression4trials
schizophrenia4trials
migraine_headache2trials
bipolar_disorder2trials
multiple_sclerosis2trials
other_neurology2trials
stroke1trials
Leading indexed sponsors
Sumitomo Pharma America, Inc.4trials
Pfizer3trials
AbbVie3trials
Boehringer Ingelheim3trials
UCB Pharma2trials
Novo Nordisk A/S2trials
Hoffmann-La Roche2trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2trials
Biotronik SE & Co. KG1trials
Biohaven Therapeutics Ltd.1trials